# 2026-19283: FDA Seeks Feedback on Fast-Track Product Permit Forms

2026-19283, Agency Information Collection Activities; Proposed Collection; Comment Request; Temporary Marketing Permit Applications, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-09-21, effective Either electronic or written comments on the collection of information must be submitted by November 20, 2026.; PRIA reads it as touching household money (as of 2026-09-28).

- Canonical: https://policyrisk.com/federal-register/2026-19283
- As of: 2026-09-28
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-19283
- Title: Agency Information Collection Activities; Proposed Collection; Comment Request; Temporary Marketing Permit Applications
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 59788
- Published: 2026-09-21
- Effective: Either electronic or written comments on the collection of information must be submitted by November 20, 2026.
- Comments close: 2026-11-20
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-09-28

## In one line

FDA Seeks Feedback on Fast-Track Product Permit Forms

## Summary

The FDA wants your thoughts on how they collect info for temporary marketing permits, which help companies get products to market quickly. This affects businesses applying for these permits and aims to keep the process smooth without extra costs or delays. You’ve got until November 20, 2026, to share your comments and help shape the rules!

## Abstract

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on reporting requirements contained in existing FDA regulations governing temporary marketing permit applications.

## Effects PRIA read

- TMP application paperwork burden: cost, medium. If your food business files for a Temporary Marketing Permit (TMP) under 21 CFR 130.17(c), FDA estimates each response takes 25 hours. The table shows 2 responses per respondent (50 hours per respondent) and 13 respondents annually, for a total of 650 hours.
- TMP extension paperwork burden: cost, low. For requests to extend a TMP under 21 CFR 130.17(i), FDA estimates each response takes 2 hours. The table shows 2 responses for the (one) respondent, totaling 4 hours annually.
- Guidance available for TMP applicants: benefit, low. FDA provides a guidance titled "Temporary Permits for Interstate Shipment of Experimental Packs of Food Varying from the Requirements of Definitions and Standards of Identity: Guidance for Industry" (November 2021) on its website to assist respondents with the TMP process.
- No capital or O&M costs claimed: benefit, low. FDA states there are no capital costs or operating and maintenance (O&M) costs associated with this information collection for TMPs.

## Related documents

- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27
- [2026-20727](https://policyrisk.com/federal-register/2026-20727): Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorgani…, 2026-10-09

## Sources
- [2026-19283 on federalregister.gov](https://www.federalregister.gov/documents/2026/09/21/2026-19283/agency-information-collection-activities-proposed-collection-comment-request-temporary-marketing)
- [2026-19283 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-09-21/pdf/2026-19283.pdf)

## Related
- [Previous: 2026-19282, Agency Information Collection Activities; Proposed Collection; Comment Request;…](https://policyrisk.com/federal-register/2026-19282)
- [Next: 2026-19284, Agency Information Collection Activities; Submission for Office of Management a…](https://policyrisk.com/federal-register/2026-19284)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-19283 (as of 2026-09-28).